84 F Clouds
Thursday, Jul 18 2024, 06:05 AM
Close Ad
Back To Listing

HSA recalls Metformin ER tablets

Local News 12 Jun, 2020 Follow News

HSA recalls Metformin ER tablets


The US Food and Drug Administration (FDA) has recommended voluntary recall of certain extended-release (ER) versions of metformin after testing revealed a contaminant in these products. The HSA, in keeping with this advisory, is recalling all Metformin ER tablets. 


Metformin is the most commonly prescribed drug used to treat type 2 diabetes worldwide. As a result of the advisory, HSA’s manufacturer, Apotex Corp has recalled metformin hydrochloride 500 mg Extended Release tablets. The recall does not include the regular release Metformin 500mg tablets.


For those patients taking Metformin ER, please contact your physician or pharmacist to facilitate the relevant adjustment.





As the nation’s principal healthcare provider, the Cayman Islands Health Services Authority (HSA) offers the broadest range of medical and specialist services in the Cayman Islands. We have seven locations throughout all three islands, which include the Cayman Islands Hospital in Grand Cayman, four district health centres (East End, North Side, West Bay, Bodden Town), Faith Hospital in Cayman Brac and the Little Cayman Clinic.

Comments (0)

We appreciate your feedback. You can comment here with your pseudonym or real name. You can leave a comment with or without entering an email address. All comments will be reviewed before they are published.

* Denotes Required Inputs